Beta Glucan Research Glossary

The branch of the immune system that develops specific responses to recognized antigens. Involves T cells and B cells that remember prior exposures. Beta glucan primarily activates innate immunity, but innate activation through macrophages and dendritic cells bridges to adaptive responses via cytokine signaling.

Programmed cell death — a controlled process where a cell self-destructs. NK cells trigger apoptosis in tumor cells and virus-infected cells by releasing perforin and granzymes. Some Aureobasidium beta glucan studies document enhanced apoptosis induction in cancer cell lines following NK cell activation.

A polymorphic black yeast (fungus) found naturally in soil, plant surfaces, and aquatic environments worldwide. Classified as BSL-1 (Biosafety Level 1 — lowest risk). Produces beta glucan and pullulan as part of its cell wall during growth. Used commercially for beta glucan production via controlled fermentation.

A polysaccharide composed of glucose units connected by β-glycosidic bonds. The linkage pattern determines biological activity. β-1,3/1,6-glucans (from yeast and fungi including Aureobasidium) activate Dectin-1 and CR3 immune receptors. β-1,3/1,4-glucans (from oat and barley) are effective for cholesterol reduction but do not significantly activate these immune pathways.

Cell surface proteins that specifically bind beta glucan molecules, triggering downstream immune signaling. Key receptors include Dectin-1 (CLEC7A), CR3 (Complement Receptor 3 / CD11b), and TLR2 (Toll-Like Receptor 2). Each receptor activates different immune pathways upon beta glucan binding.

A substance that modifies the body’s biological response to disease — particularly immune responses. Beta glucan is classified as a BRM because it modulates innate immunity without being an antigen itself. The term is used in cancer immunotherapy contexts where BRMs are studied as adjuncts to chemotherapy.

In beta glucan chemistry, the ratio of 1,6-branch points relative to the 1,3-backbone. A higher branching ratio generally correlates with stronger Dectin-1 binding affinity. Aureobasidium pullulans produces beta glucan with a specific branching ratio determined by fermentation conditions — a key quality parameter in research-grade preparations.

An integrin receptor expressed on NK cells, macrophages, and neutrophils. CR3 has two binding sites — one for complement fragment iC3b and one for β-1,3-glucan. When beta glucan binds CR3 on NK cells, it primes them for enhanced cytotoxic activity against tumor cells. This “priming” mechanism is central to anti-tumor studies on Aureobasidium beta glucan.

Small signaling proteins secreted by immune cells that regulate immune activity. In beta glucan research, key cytokines include: TNF-α (tumor necrosis factor-alpha), IL-6 (interleukin-6), IL-12 (interleukin-12), and IFN-γ (interferon-gamma). Their production is measured to quantify macrophage and dendritic cell activation.

The ability of immune cells (particularly NK cells and cytotoxic T cells) to kill target cells such as tumor cells or virus-infected cells. Measured in vitro using assays such as the chromium-51 release assay or LDH release assay. Studies on Aureobasidium beta glucan document increased NK cytotoxicity following beta glucan treatment.

A C-type lectin receptor (gene: CLEC7A) expressed on macrophages, dendritic cells, monocytes, and neutrophils. Dectin-1 is the primary pattern recognition receptor for β-1,3-glucan. Binding triggers Syk kinase → Card9 → NF-κB signaling cascade → cytokine production + phagocytosis. Highly relevant to Aureobasidium beta glucan’s immune mechanism because β-1,3/1,6 structure matches Dectin-1 binding geometry.

Professional antigen-presenting cells that bridge innate and adaptive immunity. Dendritic cells express Dectin-1 and are activated by beta glucan to produce IL-12 — a key cytokine that drives T cell differentiation toward Th1 responses. Beta glucan-stimulated dendritic cells are studied for their role in priming anti-tumor T cell responses.

A metabolic process where microorganisms convert substrates into products under controlled conditions. For Aureobasidium pullulans, fermentation is the production method for beta glucan: the yeast is cultured in bioreactors, secreting beta glucan into the fermentation medium. Parameters (pH, temperature, nutrient composition, aeration) control molecular weight and branching ratio of the output polysaccharide.

A covalent bond that links two sugar (monosaccharide) units in a polysaccharide. The β configuration means the bond is equatorial, creating a flat, ribbon-like conformation recognized by immune receptors. The position numbers (1,3 or 1,6) refer to the carbon atoms connected. β-1,3 linkages form the backbone; β-1,6 linkages form branches.

The first line of immune defense — rapid, non-specific responses that do not require prior exposure. Includes macrophages, NK cells, dendritic cells, and neutrophils. Beta glucan activates innate immunity through Dectin-1 and CR3 receptors. The innate response also initiates adaptive immunity by activating antigen-presenting cells.

A family of cytokines with potent antiviral and immunomodulatory functions. Type I interferons (IFN-α, IFN-β) are produced rapidly in response to viral infection. IFN-γ (Type II) activates macrophages and NK cells. Aureobasidium beta glucan studies document upregulation of interferon-stimulated genes (ISGs) through a Dectin-1 independent pathway — evidence of antiviral immune priming.

Genes whose transcription is upregulated by interferon signaling. ISGs encode proteins with antiviral functions including viral sensor molecules, restriction factors, and immune activators (e.g., OAS1, MX1, IFIT1). Aureobasidium beta glucan has been shown to upregulate ISGs in macrophages through a Dectin-1 independent pathway — one reason it is studied for antiviral potential against influenza and SARS-CoV-2.

A substance that modifies immune system activity — either stimulating (immunostimulant) or suppressing (immunosuppressant) immune responses. Beta glucan from Aureobasidium pullulans is classified as an immunomodulator because it enhances innate immune responses without causing inflammatory pathology at studied doses.

A phagocytic cell of the innate immune system derived from monocytes. Macrophages express Dectin-1 and are a primary target of beta glucan. Upon Dectin-1 binding, they are activated to: (1) increase phagocytic activity, (2) produce pro-inflammatory cytokines (TNF-α, IL-6, IL-12), and (3) present antigens to T cells. Central to beta glucan’s immune-activating effects.

The mass of a molecule, expressed in Daltons (Da) or kilodaltons (kDa). For polysaccharides like beta glucan, molecular weight affects solubility, viscosity, and receptor binding affinity. High molecular weight beta glucan (>500 kDa) tends to form triple-helix structures associated with stronger Dectin-1 activation. Fermentation conditions control the MW distribution of Aureobasidium beta glucan.

A transcription factor that regulates the expression of genes involved in immune and inflammatory responses. When Dectin-1 binds beta glucan, it triggers a signaling cascade (Syk → Card9 → IKK complex) that activates NF-κB — which then drives transcription of cytokines (TNF-α, IL-6, IL-12) and other immune activation genes. NF-κB is a central hub in beta glucan-mediated immune activation.

A cytotoxic lymphocyte of the innate immune system that kills tumor cells and virus-infected cells without requiring antigen presentation. NK cells express CR3 receptors that bind beta glucan, priming them for enhanced cytotoxicity. Multiple Aureobasidium beta glucan studies measure NK cell activity as a primary endpoint. Higher NK activity correlates with tumor killing in vitro and tumor growth inhibition in vivo.

Receptors on innate immune cells that detect conserved molecular patterns called PAMPs (Pathogen-Associated Molecular Patterns) or DAMPs (Damage-Associated Molecular Patterns). Dectin-1 and TLR2 are PRRs that recognize beta glucan. Because beta glucan is a fungal cell wall component (PAMP), it activates immune defenses even when isolated from the organism.

The process by which phagocytic cells (macrophages, neutrophils, dendritic cells) engulf and destroy pathogens, dead cells, or particles. Dectin-1 stimulation by beta glucan enhances macrophage phagocytic activity. Enhanced phagocytosis is one of the measured outcomes in in vitro Aureobasidium beta glucan studies.

A large carbohydrate molecule composed of many monosaccharide (sugar) units linked by glycosidic bonds. Beta glucan is a polysaccharide made of glucose units. Other polysaccharides include starch, cellulose, chitin, and hyaluronic acid. The molecular structure (linkage type, branching pattern, molecular weight) determines the biological activity of a polysaccharide.

A water-soluble polysaccharide produced by Aureobasidium pullulans alongside beta glucan. Pullulan has α-1,4/1,6 linkages (not β) and is widely used as a food additive, film-forming agent, and pharmaceutical excipient. It is distinct from beta glucan in structure and biological activity — pullulan does not activate Dectin-1 immune pathways.

The gold standard clinical study design. Participants are randomly assigned to treatment or control groups, minimizing selection bias. Blinding (single or double) prevents placebo effects and observer bias. RCTs provide the strongest evidence for clinical efficacy. The Research Archive at aureobasidium.org indexes all published RCTs on Aureobasidium pullulans beta glucan with DOI and PMID references.

The strength of interaction between a molecule (ligand) and its receptor. Measured by Kd (dissociation constant) — lower Kd = higher affinity. For beta glucan, binding affinity to Dectin-1 depends on the degree of branching (1,6-branch density) and molecular conformation (triple helix vs. random coil). Higher affinity correlates with stronger immune activation in cell assays.

An intracellular signaling enzyme activated when Dectin-1 binds beta glucan. Syk phosphorylates downstream proteins (CARD9, PKCδ) that propagate the signal to NF-κB — ultimately triggering cytokine gene transcription. Syk inhibitors abolish beta glucan-induced cytokine production, confirming its essential role in the Dectin-1 pathway.

A family of pattern recognition receptors that detect microbial signatures and activate innate immunity. TLR2 has been shown to cooperate with Dectin-1 in response to fungal beta glucan — enhancing cytokine production via synergistic signaling. TLR4 recognizes LPS (bacterial endotoxin). TLR activation also triggers NF-κB, similar to the Dectin-1 pathway.

A three-stranded helical conformation adopted by high-molecular-weight β-1,3-glucans in solution. The triple helix is the biologically active conformation — it fits the Dectin-1 binding pocket geometry and has higher immunostimulatory activity than the random-coil form. High MW and appropriate branching are required for triple-helix formation. Harsh extraction conditions (high pH, high temperature) can denature the triple helix.

An endogenous glycoprotein with anti-angiogenic and tumor-suppressive properties. TSP-1 inhibits new blood vessel formation (angiogenesis) in tumors — limiting their growth and metastasis. Studies on Aureobasidium pullulans beta glucan document upregulation of TSP-1 as a proposed mechanism for anti-tumor effects, in addition to NK cell activation.

A pro-inflammatory cytokine produced by macrophages following Dectin-1 activation. TNF-α has multiple immune functions including: activating neutrophils, inducing fever, and directly causing apoptosis in some tumor cells. It is one of the primary cytokines measured to confirm macrophage activation in beta glucan studies.

The naturally occurring, unmodified form of an organism as found in nature. Aureobasidium pullulans exists as multiple wild-type strains with variations in melanin content, growth rate, and polysaccharide production. Commercial beta glucan production selects for specific strains optimized for yield and consistency. Research publications typically specify the strain used, as strain differences can affect beta glucan characteristics.